Preparation techniques before embryo transfer do not seem to affect pregnancy rates, according to results of a recent review.

Revised ACC immunization guidance provides evidence-based recommendations for influenza, pneumococcal, COVID-19, RSV, and zoster vaccines.

More than 1 in 10 women (12%) positive for bacterial vaginosis are infected with at least 1 sexually transmitted infection.

Evolving guidance and gaps in routine immunization present ongoing challenges for clinicians advocating for vaccine ...

Early remdesivir therapy reduces all-cause graft loss and CV event risks in KT recipients with acute symptomatic COVID-19.

For adults with postoperative endophthalmitis, conducting a randomized trial of early vitrectomy vs standard-of-care treatment is feasible.

Prepared foods sold at some stores are being pulled from shelves because the jalapeños they contain may carry Salmonella.

Nirsevimab immunization in infants younger than 12 months is associated with a significantly reduced risk for IPD.

Tuberculosis risk among patients receiving systemic therapy for dermatologic diseases varied by treatment class and regional burden.

Delayed antibiotics increase in-hospital mortality only in patients presenting with septic shock, irrespective of immune status.

The FDA approved mFlusiva, the first mRNA-based influenza vaccine, for adults 50 years and older with accelerated approval for those 65 and older.

The FDA accepted an sBLA for clesrovimab to prevent RSV lower respiratory tract disease in high-risk children through their second season.